Risk of nonacral cutaneous melanoma after the diagnosis of acral melanoma

Nicholas R. Kurtansky; Rachel N. Manci; Danielle M. Bello; Adewole S. Adamson; Alexander N. Shoushtari; Mackenzie R. Wehner; Charlotte E. Ariyan; Ashfaq A. Marghoob; Michael A. Marchetti; Veronica Rotemberg

doi:10.1111/bjd.21251

Risk of nonacral cutaneous melanoma after the diagnosis of acral melanoma

Nicholas R. Kurtansky, Rachel N. Manci, Danielle M. Bello, Adewole S. Adamson, Alexander N. Shoushtari, Mackenzie R. Wehner, Charlotte E. Ariyan, Ashfaq A. Marghoob, Michael A. Marchetti, Veronica Rotemberg

Health Services Research

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Pages (from-to)	430-432
Number of pages	3
Journal	British Journal of Dermatology
Volume	187
Issue number	3
DOIs	https://doi.org/10.1111/bjd.21251
State	Published - Sep 2022

ASJC Scopus subject areas

Dermatology

Access to Document

10.1111/bjd.21251

Cite this

@article{c39c67e34d8940589ec2af3e52b5bed9,

title = "Risk of nonacral cutaneous melanoma after the diagnosis of acral melanoma",

author = "Kurtansky, {Nicholas R.} and Manci, {Rachel N.} and Bello, {Danielle M.} and Adamson, {Adewole S.} and Shoushtari, {Alexander N.} and Wehner, {Mackenzie R.} and Ariyan, {Charlotte E.} and Marghoob, {Ashfaq A.} and Marchetti, {Michael A.} and Veronica Rotemberg",

note = "Funding Information: Funding sources: this study was supported in part by Memorial Sloan Kettering Cancer Center{\textquoteright}s NIH National Cancer Institute Cancer Center support grant P30 CA008748 (N.R.K., R.N.M., D.M.B., A.N.S., C.E.A., A.A.M., M.A.M. and V.R.) and Melanoma Research Alliance Young Investigator Award 614197 (V.R.). A.S.A. is supported by the Dermatology Foundation Public Health Career Development Award, by the National Institutes of Health under grant NIH UL1 TR002645, by the American Cancer Society, by Meredith{\textquoteright}s Mission for Melanoma, and by the Brown Skin Too Foundation. M.R.W. is a Cancer Prevention and Research Institute of Texas (CPRIT) Scholar in Cancer Research. Funding Information: Funding sources: this study was supported in part by Memorial Sloan Kettering Cancer Center{\textquoteright}s NIH National Cancer Institute Cancer Center support grant P30 CA008748 (N.R.K., R.N.M., D.M.B., A.N.S., C.E.A., A.A.M., M.A.M. and V.R.) and Melanoma Research Alliance Young Investigator Award 614197 (V.R.). A.S.A. is supported by the Dermatology Foundation Public Health Career Development Award, by the National Institutes of Health under grant NIH UL1 TR002645, by the American Cancer Society, by Meredith{\textquoteright}s Mission for Melanoma, and by the Brown Skin Too Foundation. M.R.W. is a Cancer Prevention and Research Institute of Texas (CPRIT) Scholar in Cancer Research.",

year = "2022",

month = sep,

doi = "10.1111/bjd.21251",

language = "English (US)",

volume = "187",

pages = "430--432",

journal = "British Journal of Dermatology",

issn = "0007-0963",

publisher = "Wiley-Blackwell",

number = "3",

}

TY - JOUR

T1 - Risk of nonacral cutaneous melanoma after the diagnosis of acral melanoma

AU - Kurtansky, Nicholas R.

AU - Manci, Rachel N.

AU - Bello, Danielle M.

AU - Adamson, Adewole S.

AU - Shoushtari, Alexander N.

AU - Wehner, Mackenzie R.

AU - Ariyan, Charlotte E.

AU - Marghoob, Ashfaq A.

AU - Marchetti, Michael A.

AU - Rotemberg, Veronica

N1 - Funding Information: Funding sources: this study was supported in part by Memorial Sloan Kettering Cancer Center’s NIH National Cancer Institute Cancer Center support grant P30 CA008748 (N.R.K., R.N.M., D.M.B., A.N.S., C.E.A., A.A.M., M.A.M. and V.R.) and Melanoma Research Alliance Young Investigator Award 614197 (V.R.). A.S.A. is supported by the Dermatology Foundation Public Health Career Development Award, by the National Institutes of Health under grant NIH UL1 TR002645, by the American Cancer Society, by Meredith’s Mission for Melanoma, and by the Brown Skin Too Foundation. M.R.W. is a Cancer Prevention and Research Institute of Texas (CPRIT) Scholar in Cancer Research. Funding Information: Funding sources: this study was supported in part by Memorial Sloan Kettering Cancer Center’s NIH National Cancer Institute Cancer Center support grant P30 CA008748 (N.R.K., R.N.M., D.M.B., A.N.S., C.E.A., A.A.M., M.A.M. and V.R.) and Melanoma Research Alliance Young Investigator Award 614197 (V.R.). A.S.A. is supported by the Dermatology Foundation Public Health Career Development Award, by the National Institutes of Health under grant NIH UL1 TR002645, by the American Cancer Society, by Meredith’s Mission for Melanoma, and by the Brown Skin Too Foundation. M.R.W. is a Cancer Prevention and Research Institute of Texas (CPRIT) Scholar in Cancer Research.

PY - 2022/9

Y1 - 2022/9

UR - http://www.scopus.com/inward/record.url?scp=85132643554&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85132643554&partnerID=8YFLogxK

U2 - 10.1111/bjd.21251

DO - 10.1111/bjd.21251

M3 - Letter

C2 - 35318644

AN - SCOPUS:85132643554

SN - 0007-0963

VL - 187

SP - 430

EP - 432

JO - British Journal of Dermatology

JF - British Journal of Dermatology

IS - 3

ER -

Risk of nonacral cutaneous melanoma after the diagnosis of acral melanoma

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this